Side effects caused by the few current treatment options are seriously objectionable.

Peter Mays, Vice President, Pharmaceutical Development the Femme Pharma Global Healthcare.. The company is now engineering its patented platform technology to provide a topical cream chest pain chest pain develop, And large, side effects caused by the few current treatment options are seriously objectionable. ‘If a woman goes to her doctor today for drugs to alleviate pain in the chest likely to face likely to face several inferior choices: an FDA – approved prescription drugs that usually causes unpleasant side effects such as facial hair growth, weight gain and acne, or a over-the-counter pain reliever that does not address the underlying causes of chest pain, ‘said Gerianne Tringali DiPiano, President and CEO of Femme Pharma Global Healthcare.

Founded in 1996, Femme Pharma ‘s Global Healthcare on the development of safe and effective drugs minimizing or eliminating the side effects of many drug therapies by designing treatments in a way that suits the female anatomy associated concentrates. The company has already with the development of with the development of a safe and effective treatment of endometriosis. Upon successful completion of the Phase 2 studies for this product, it was acquired by KV Pharmaceutical, its its development and bring the drug to market. Other recent efforts a product of urinary incontinence in Phase 2 clinical trials ,, and products to treat dysmenorrhea and dysfunctional uterine bleeding in preclinical development. Femme Pharma Global Health Care.Contact:. Polly Young Tel:+44 1243 seven hundred and seventy thousand six hundred and thirty-three E-mail:.

The Jadad AR, Cook DJ, Jones A, classes HP, Tugwell P, Moher M, et al Methodology and reports out of systematic reviews of and meta – analysies. A comparison between the Cochrane reviews with items in the paper-based Journal of.

Related Articles

Other Articles from "nephrology":